These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26699867)

  • 1. Patient Characteristics and Antithrombotic Prescribing Patterns in Patients With Atrial Fibrillation in Tasmania.
    Bista D; Chalmers L; Peterson GM; Bereznicki LRE
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):438-444. PubMed ID: 26699867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities.
    Singh P; Arrevad PS; Peterson GM; Bereznicki LR
    J Clin Pharm Ther; 2011 Apr; 36(2):166-71. PubMed ID: 21366645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?
    Bista D; Chalmers L; Peterson GM; Bereznicki LRE
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):573-578. PubMed ID: 27071408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study.
    Admassie E; Chalmers L; Bereznicki LR
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1681-1689. PubMed ID: 28939954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.
    Ermini G; Perrone V; Veronesi C; Degli Esposti L; Di Pasquale G
    Vasc Health Risk Manag; 2017; 13():239-246. PubMed ID: 28740396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.
    Bajorek B; Magin PJ; Hilmer S; Krass I
    J Clin Pharm Ther; 2016 Aug; 41(4):432-40. PubMed ID: 27338004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
    Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome.
    Paciaroni M; Agnelli G; Caso V; Venti M; Milia P; Silvestrelli G; Parnetti L; Biagini S
    J Thromb Haemost; 2005 Jun; 3(6):1218-23. PubMed ID: 15892862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk?
    Guo Y; Wu Q; Zhang L; Yang T; Zhu P; Gao W; Zhao Y; Gao M
    Clin Interv Aging; 2010 May; 5():157-62. PubMed ID: 20517485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
    O'Donnell M; Weitz JI
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S72-82. PubMed ID: 15152749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.